Chris Meda

Chris Meda is an accomplished executive with extensive experience in the biotechnology and diagnostics sectors. Currently serving as Chief Commercial Officer at AmplifiDx since December 2023, Chris also holds a Board Member position at the California Breast Cancer Research Program and has been the Owner of RxDxLink™ since 2007, providing consulting services to early-stage companies. Previous leadership roles include Chief Business Officer at IncellDx, President at Response Genetics, and CEO of Arcxis Biotechnologies. Chris’s background also includes significant experience at F. Hoffmann-La Roche as VP of Women's Health and Business Development, where multiple PCR tests were successfully launched. Education includes a BS in Music from the State University of New York College at Potsdam and an MS in Music Therapy from Michigan State University.